Diphtheria, Tetanus, and acellular Pertussis vaccine
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:abbreviation |
gptkb:DTaP
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:boosters |
gptkb:Tdap
|
| gptkbp:broadcastOn |
5 doses
|
| gptkbp:contains |
diphtheria toxoid
tetanus toxoid acellular pertussis antigens |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:developedBy |
late 1990s
|
| gptkbp:firstDoseAge |
2 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diphtheria, Tetanus, and acellular Pertussis vaccine
|
| gptkbp:prevention |
diphtheria
tetanus pertussis |
| gptkbp:recommendation |
children
|
| gptkbp:replacedBy |
gptkb:DTwP
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
swelling at injection site redness at injection site mild pain |
| gptkbp:usedIn |
gptkb:Europe
gptkb:United_States many countries worldwide |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:DTaP
|
| gptkbp:bfsLayer |
6
|